RESUMO

The therapeutics results with the use of different drugs (diazepam, nitrazepam, clonazepam, diphenylhydantoin, barbiturates--phenobarbital and primidone--, sodium dipropylacetate and ACTH) in twenty-nine patients with Lennox--Gastaut syndrome are carefully analysed. The effect of each drug on seizures (tonic, tonic-clonic, clonic, myoclonic or myoclonic-atonic, atonic and atypical absences) during the first month of each treatment is discussed. The "specific" use of each drug on the various forms of epileptic seizures is determined and the possibility of crisis control with reduction of the drugs dosage is verified.

Assuntos

Anticonvulsivantes/uso terapêutico , Epilepsia/tratamento farmacológico , Convulsões/tratamento farmacológico , Hormônio Adrenocorticotrópico/uso terapêutico , Anticonvulsivantes/administração & dosagem , Barbitúricos/uso terapêutico , Criança , Pré-Escolar , Clonazepam/uso terapêutico , Diazepam/uso terapêutico , Eletroencefalografia , Epilepsia/classificação , Feminino , Humanos , Lactente , Masculino , Nitrazepam/uso terapêutico , Fenobarbital/uso terapêutico , Fenitoína/uso terapêutico , Primidona/uso terapêutico , Espasmos Infantis/tratamento farmacológico , Síndrome